Tag: life sciences
-
Personal Cancer Vaccine Induces Tumor Shrinkage
Interim results from a clinical trial show some head and neck cancer patients receiving a personalized vaccine and immunotherapy report tumor shrinkage.
-
Coronavirus Antibody Maker Raises $80M in New Funds
A company developing synthetic antibodies to protect against a range of coronavirus infections, including Covid-19, is raising $80 million in new venture funds.
-
Salk, Energy Utility Partner on Carbon Capture Plants
A California energy utility and Salk Institute are collaborating on engineering new plant varieties that capture and store more carbon dioxide in the ground.
-
Electric Crispr Chip Quickly Detects Covid-19 Virus
An engineering lab developed a chip device that uses gene editing and an electric field to detect viruses responsible for Covid-19 infections.
-
Oral Drug Delivery Company Acquired in $1.8B Deal
Emisphere Technologies, developers of a process that makes biologic drugs available as oral medicines is being acquired by drug maker Novo Nordisk.
-
Diabetes Foundation, Lilly Invest in Protein Biotech
A biotechnology company creating synthetic sensing proteins received equity investments to support work on its variable-release insulin for people with type 1 diabetes.
-
Crispr Therapy Shown to Help Blood Disorder Patients
Interim clinical trial results show an experimental treatment derived from gene-edited stem cells relieves symptoms in patients with severe inherited blood diseases.
-
Flexible Device Attaches to Heart, Monitors Functions
Biomedical engineers designed a thin flexible implantable patch that attaches to the heart, monitors its functions, and can perform therapeutics.
-
Trial Shows Covid-19 Vaccine Safety, Immune Response
First results from an early-stage clinical trial show an RNA-based vaccine to prevent Covid-19 infections is safe and produces a complex immune response.
-
Inhaled Dry-Powder Covid-19 Antibodies in the Works
Two biotechnology companies are developing synthetic antibodies to treat Covid-19 infections formulated as an inhaled dry powder rather than an infusion.